News Axovant axes dementia drug after disastrous trial results Intepirdine seemed to make symptoms worse in Lewy body disease
Novartis Novartis adds Promacta to breakthrough status roll-call Drug could get new indication based on NIH research
News NHS should fund GSK's £526,000 "bubble baby" drug - NICE Strimvelis is most expensive drug cleared by NICE
Events Partner Content Blockchain for Clinical Trials Forum Setting a New Standard for Optimizing Clinical Trials
News GSK looks to expand reach of key COPD drug Trelegy GlaxoSmithKline and partner Innoviva are seeking an expansion to the US label of their Trelegy Ellipta lung drug.
R&D The long-delayed promise of the microbiome, with Sam Possemi... Sam Possemiers, CEO of MRM Health, believes that the microbiome space is finally coming into maturity.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
